Inmunología, Oftalmología y ORL
Departamento
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (14)
2024
-
T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)
Journal of Pediatrics, Vol. 272
2023
2021
-
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures
Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983
-
T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794
2019
-
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
American Journal of Ophthalmology, Vol. 200, pp. 85-94
-
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis
Clinica Chimica Acta, Vol. 488, pp. 135-142
2018
-
Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations
Farmacia Hospitalaria, Vol. 42, Núm. 2, pp. 82-88
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
2010
-
Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation
Clinical Cancer Research, Vol. 16, Núm. 17, pp. 4382-4391
-
Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain
Cancer Cell, Vol. 17, Núm. 2, pp. 160-172
-
VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration
Blood, Vol. 115, Núm. 4, pp. 846-849
2008
-
Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration
Blood, Vol. 111, Núm. 1, pp. 383-386
-
ά4Β1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells
Blood, Vol. 112, Núm. 1, pp. 169-178
2003
-
Mutations of CD40 ligand in two patients with hyper-IgM syndrome
Immunobiology, Vol. 207, Núm. 4, pp. 285-294